Published in J Biol Chem on September 22, 1995
Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis (2000) 2.59
Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res (2009) 2.01
AHR-mediated immunomodulation: the role of altered gene transcription. Biochem Pharmacol (2008) 1.46
Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy. Infect Disord Drug Targets (2010) 1.44
The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function. Protein Sci (1998) 1.24
Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. Biochem J (1998) 1.13
Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease. Proc Natl Acad Sci U S A (2011) 1.05
The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells. PLoS One (2012) 1.01
Treatment of multiple sclerosis: current concepts and future perspectives. J Neurol (2011) 0.98
Purine and pyrimidine pathways as targets in Plasmodium falciparum. Curr Top Med Chem (2011) 0.93
Regulation of STATs by polycystin-1 and their role in polycystic kidney disease. JAKSTAT (2013) 0.91
Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism. BMC Genomics (2008) 0.87
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. Drug Des Devel Ther (2014) 0.85
An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors. Hum Mol Genet (2011) 0.84
The effects of leflunomide on CD4(+)CD25 (+)Foxp3 (+) T regulatory cells in mice receiving allogeneic bone marrow transplantation. Inflamm Res (2011) 0.81
Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts. Clin Exp Immunol (2004) 0.81
Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells. Oncotarget (2016) 0.78
Preliminary study on the immunologic background of good clinical outcome in rheumatoid arthritis patients after one month therapy with leflunomide. Rheumatol Int (2008) 0.76
Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide. Clin Exp Immunol (1999) 0.75
Dihydroorotate dehydrogenase Inhibitors Target c-Myc and Arrest Melanoma, Myeloma and Lymphoma cells at S-phase. J Cancer (2017) 0.75
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Rapid responses of British butterflies to opposing forces of climate and habitat change. Nature (2001) 8.75
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads--80 case reports. Chest (1997) 4.29
Consensus statement on the live organ donor. JAMA (2000) 3.29
X-ray analysis of the eye lens protein gamma-II crystallin at 1.9 A resolution. J Mol Biol (1983) 3.04
The molecular structure and stability of the eye lens: x-ray analysis of gamma-crystallin II. Nature (1981) 3.03
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Surface structures involved in target recognition by human cytotoxic T lymphocytes. Science (1982) 2.52
A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature (1987) 2.48
Characterization of an antigen expressed by human natural killer cells. J Immunol (1983) 2.44
Subpopulations of human peripheral T gamma delta lymphocytes. Immunol Today (1989) 2.39
The human T-cell receptor. Annu Rev Immunol (1984) 2.23
Case study: use of differential reinforcement to suppress self-injurious and aggressive behavior. Psychol Rep (1976) 2.23
A novel subset of human lymphocytes with a T cell receptor-gamma complex. J Exp Med (1987) 2.12
Expression of a maize sucrose phosphate synthase in tomato alters leaf carbohydrate partitioning. Plant Cell (1991) 2.09
An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol (1992) 2.03
Anthrax: the disease in relation to vaccines. Vaccine (1984) 1.99
Characterization of lexB mutations in Escherichia coli K-12. J Bacteriol (1977) 1.99
Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature (1983) 1.93
Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol (1991) 1.84
The genetic characterization of lexB32, lexB33 and lexB35 mutations of Escherichia coli: location and complementation pattern for UV resistance. Mol Gen Genet (1977) 1.83
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. Science (1985) 1.83
LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med (1990) 1.83
Effect of the neighborhood health center on the use of pediatric emergency departments in Rochester, New York. N Engl J Med (1971) 1.80
Polyclonal and monoclonal antibody and PCR-amplified small-subunit rRNA identification of a microsporidian, Encephalitozoon hellem, isolated from an AIDS patient with disseminated infection. J Clin Microbiol (1994) 1.80
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes. Eur J Immunol (1988) 1.76
T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol (1989) 1.72
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function. J Exp Med (1983) 1.62
A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes. J Exp Med (1988) 1.61
Some aspects of immunity in patients with cystic fibrosis. Clin Exp Immunol (1974) 1.60
Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. Hum Immunol (1981) 1.57
Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood. J Immunol (1982) 1.56
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56
Multiplex allele-specific target amplification based on PCR suppression. Proc Natl Acad Sci U S A (2001) 1.54
Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional V beta subfamilies. Eur J Immunol (1991) 1.53
Glucan synthase complex of Aspergillus fumigatus. J Bacteriol (2001) 1.52
Experimental transmission of legionnaires' disease by exposure to aerosols of Legionella pneumophila. Lancet (1982) 1.50
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med (1992) 1.48
T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol (1995) 1.44
Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur J Immunol (1991) 1.44
Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay. Appl Environ Microbiol (1985) 1.43
The structure of avian eye lens delta-crystallin reveals a new fold for a superfamily of oligomeric enzymes. Nat Struct Biol (1994) 1.41
Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Eur J Biochem (1985) 1.41
The membrane-associated 'cortex' of animal cells: its structure and mechanical properties. J Cell Sci Suppl (1986) 1.41
Conference report: community-based health promotion--state of the art and recommendations for the future. Am J Prev Med (1997) 1.41
[Precaution in the thrombolytic treatment of myocardial infarction]. Presse Med (1989) 1.40
Characterization of human peripheral lymphocytes expressing the CD3-gamma/delta complex with anti-receptor monoclonal antibodies. J Immunol (1988) 1.40
[Severe early pulmonary embolism after blockage of the vena cava]. Presse Med (1994) 1.39
Intrapericardial bronchogenic cyst: an unusual cause of CA 19-9 increase. Eur J Med (1992) 1.39
[Duration of antivitamin K therapy in venous thromboembolic disease]. Arch Mal Coeur Vaiss (1995) 1.38
Prophage induction and cell division in E. coli. V. Dominance and complementation analysis in partial diploids with pleiotropic mutations (tif, recA, zab and lexB) at the recA locus. Mol Gen Genet (1977) 1.38
CD1c as a target recognition structure for human T lymphocytes: analysis with peripheral blood gamma/delta cells. Eur J Immunol (1990) 1.36
Dose standardisation of botulinum toxin. Lancet (1994) 1.35
Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur J Biochem (1982) 1.34
Conformational flexibility in a small globular hormone: x-ray analysis of avian pancreatic polypeptide at 0.98-A resolution. Biopolymers (1983) 1.33
Evaluation of a monoclonal antibody-based immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol (1988) 1.33
T cells expressing gamma delta chain receptors in rheumatoid arthritis. J Autoimmun (1988) 1.32
Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion. J Clin Invest (1993) 1.32
Immunological study of in vitro maturation of human megakaryocytes. Br J Haematol (1984) 1.32
Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle? Mol Microbiol (1999) 1.30
Characterization of functional surface structures on human natural killer cells. Adv Immunol (1988) 1.30
Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature (1978) 1.30
Further analysis of the T cell receptor gamma/delta+ peripheral lymphocyte subset. The V delta 1 gene segment is expressed with either C alpha or C delta. J Exp Med (1990) 1.29
Studies on the human T cell receptor alpha/beta variable region genes. I. Identification of 7 additional V alpha subfamilies and 14 J alpha gene segments. Eur J Immunol (1991) 1.29
Prevention and control of hypertension by nutritional-hygienic means. Long-term experience of the Chicago Coronary Prevention Evaluation Program. JAMA (1980) 1.28
Aerosol infection of animals with strains of Legionella pneumophila of different virulence: comparison with intraperitoneal and intranasal routes of infection. J Hyg (Lond) (1983) 1.27
Molecular similarities among the adenovirus-associated virus polypeptides and evidence for a precursor protein. Virology (1977) 1.25
Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem (1983) 1.25
Clostridium botulinum toxins: nature and preparation for clinical use. Eye (Lond) (1988) 1.23
Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin. Eur J Biochem (1993) 1.22
Natural killer clones derived from fetal (25 wk) blood. Probing the human T cell receptor with WT31 monoclonal antibody. J Exp Med (1986) 1.21
Scoring systems for evaluating dietary pattern effect on serum cholesterol. Prev Med (1979) 1.20
Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect Immun (1994) 1.20
Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Immunogenetics (1994) 1.19
B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor. Proc Natl Acad Sci U S A (1982) 1.19
Proliferative responses of circulating human NK cells: delineation of a unique pathway involving both direct and helper signals. Eur J Immunol (1985) 1.18
Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus. Eur J Immunol (1992) 1.18
CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes. J Immunol (1988) 1.17
Ultrastructure of pulmonary alveoli and macrophages in experimental Legionnaires' disease. J Pathol (1983) 1.17
Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem (1986) 1.17
A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation. Eur J Immunol (1999) 1.16
Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest (1994) 1.16
Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol (1987) 1.15
Potency equivalence of botulinum toxin preparations. J R Soc Med (1994) 1.15
Behavior of osteoblast, adipocyte, and myoblast markers in genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone (2002) 1.14
[Treatment of primary cardiogenic shock by coronary transluminal angioplasty during the acute phase of myocardial infarction]. Arch Mal Coeur Vaiss (1990) 1.14
Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma. Int J Cancer (2001) 1.14
Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. Biochem J (1998) 1.13
Cloned human CD3- lymphocytes with natural killer-like activity do not express nor rearrange T cell receptor gamma genes. Eur J Immunol (1987) 1.13
In vitro processing of human tumor necrosis factor-alpha. J Biol Chem (1995) 1.12
2-(oxadiazolyl)- and 2-(thiazolyl)imidazo[1,2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors. J Med Chem (1991) 1.12